Revival of old antibiotics: structuring the re-development process to optimize usage

Clin Microbiol Infect. 2015 Oct;21(10):878-80. doi: 10.1016/j.cmi.2015.06.019. Epub 2015 Jun 25.

Authors

U Theuretzbacher¹, M Paul²

Affiliations

¹ Centre for Anti-Infective Agents, Vienna, Austria. Electronic address: [email protected].
² Division of Infectious Diseases, Rambam Health Care Campus and Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.

PMID: 26119721
DOI: 10.1016/j.cmi.2015.06.019

No abstract available

Keywords: Carbapenem-resistance; drug redevelopment; multidrug-resistant bacteria; pharmacokinetics/pharmacodynamics; regulatory drug approval.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Anti-Bacterial Agents / therapeutic use*
Drug Approval*
Drug Resistance, Multiple, Bacterial*
Gram-Negative Bacterial Infections / drug therapy*
Humans
Staphylococcal Infections / drug therapy*

Substances

Anti-Bacterial Agents